Women who take oral contraceptives containing gestodene are 5.6 times as likely to develop [[venous thromboembolism]] than women who do not take any contraceptive pill, and 1.6 times as likely to develop venous thromboembolism compared to women taking oral contraceptives containing [[levonorgestrel]].<ref>{{cite journal | author = Lidegaard| title = Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses | journal = BMJ | volume = 343 | pages = 1â€“15 | year = 2011 | doi= 10.1136/bmj.d6423 | pmid=22027398 | pmc=3202015|display-authors=etal}}</ref>

 

